Moderna provided storage update and FDA authorization for 15-doses per vial of COVID-19 vaccine
On Apr. 1, 2021, Moderna announced that based on submitted stability data, the U.S. Food and Drug Administration…
-
-
Moderna announced supply agreement to provide 13 million doses of COVID-19 vaccine to the Philippines
On Mar. 6, 2021, Moderna announced a supply agreement with the Government of The Philippines for 13 million doses…
-
European Commission purchased additional 150 million doses of COVID-19 Vaccine Moderna
On Feb. 17, 2021, Moderna announced that the European Commission had purchased an additional 150 million doses of…
-
Moderna provided U.S. COVID-19 vaccine supply update
On Feb. 16, 2021, Moderna provided a supply update for their COVID-19 Vaccine in the United States, reporting…
-
Canada purchased additional 4 million doses of Moderna’s COVID-19 vaccine
On Feb. 12, 2021, Moderna announced that the Canadian Government had increased its confirmed order commitment by 4…
-
Qatar Ministry of Public Health issued Emergency Use Authorization for COVID-19 Vaccine Moderna
On Feb. 11, 2021, Moderna announced that the Qatar Ministry of Public Health had issued an emergency use…
-
US Government purchased additional 100 million doses of Moderna’s COVID-19 Vaccine
On Feb. 11, 2021, Moderna announced that the U.S. government had purchased an additional 100 million doses of…
-
Singapore Health Sciences Authority approved interim authorization of COVID-19 Vaccine Moderna
On Feb. 3, 2021, Moderna announced that the Singapore Health Sciences Authority (HSA) had approved the interim authorization…
-
Moderna announced amendment to supply agreement with Switzerland for additional 6 million doses of COVID-19 vaccine
On Feb. 3, 2021, Moderna announced the Swiss Federal Government had increased its confirmed order commitment from 7.5…
-
Moderna confirms discussions with US Government for additional 100 million doses of COVID-19 vaccine
On Jan. 27, 2021, Moderna confirmed that the Company is in discussion with the U.S. government to purchase…
-
New genetic test for heart-attack risk launched for patients at Mass General
On Jan. 27, 2021, researchers at the Broad Institute of MIT and Harvard, and Massachusetts General Hospital’s Center…
-
Moderna provided U.S. COVID-19 vaccine supply update
On Jan. 26, 2021, Moderna reported that 30.4 million doses have been supplied to the U.S. Government to…
-
Moderna COVID-19 vaccine retained neutralizing activity against emerging variants identified in UK and South Africa
On Jan. 25, 2021, Moderna announced results from in vitro neutralization studies of sera from individuals vaccinated with…
-
Swissmedic authorized COVID-19 vaccine Moderna for Use in Switzerland
On Jan. 12, 2021, Moderna announced that Swissmedic, the Swiss Agency for Therapeutic Products, had authorized the COVID-19…
-
Biotechnology | COVID-19 | HIV | Influenza | Vaccine
Moderna announced three new development programs in infectious disease vaccines
On Jan. 11, 2021, Moderna announced that it was expanding its pipeline of innovative vaccines with three new…
-
UK medicines regulator approved Moderna vaccine as third COVID-19 vaccine
On Jan. 8, 2021, the COVID-19 vaccine developed by Moderna has today been given regulatory approval for supply…
-
UK Medicines and Healthcare products regulatory agency authorized use of COVID-19 Vaccine Moderna
On Jan. 8, 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) announced it had accepted the recommendation…
-
European Commission authorized COVID-19 vaccine Moderna in Europe
On Jan. 6, 2021, Moderna announced that the European Commission had granted a conditional marketing authorization for COVID-19…
-
Moderna provided COVID-19 vaccine supply update
On Jan. 4, 2021, Moderna announced a supply update for the Moderna COVID-19 Vaccine, increasing its base-case global…
-
Israeli Ministry of Health authorized COVID-19 Vaccine Moderna
On Jan. 4, 2021, Moderna announced that Israel’s Ministry of Health (MOH) had given authorization to import the…
-
Moderna confirmed 40 million COVID-19 vaccine dose supply agreement with Republic of Korea
On Dec. 31, 2020, Moderna confirmed it had entered into a supply agreement with the government of the…
-
Recipharm and Moderna finalized agreement for aseptic drug manufacturing and fill-finish for countries outside the U.S.
On Dec. 30, 2020, Moderna announced that they had reached an agreement to support formulation and fill-finish a…
-
Moderna confirmed discussions with government of South Korea to supply 40 million doses of COVID-19 vaccine
On Dec. 29, 2020, Moderna confirmed that the Company was engaged in discussions with the government of South…
-
Health Canada authorized Moderna COVID-19 vaccine in Canada
On Dec. 23, 2020, Moderna announced that Health Canada had authorized its vaccine against COVID-19 for the immunization…
-
Tonix Pharmaceuticals announced commercial scale vaccine manufacturing facility in Hamilton, Montana
On Dec. 23, 2020, Tonix Pharmaceuticals announced that it had completed the purchase of an approximately 44-acre site…
-
U.S. Dept. of Veterans Affairs began COVID-19 vaccinations at 128 additional sites
On Dec. 21, 2020, the U.S. Dept. of Veterans Affairs (VA) announced that it had begun COVID-19 vaccinations…
-
CDC’s ACIP announced interim recommendation for use of Moderna COVID-19 Vaccine
On Dec. 19, 2020, after a transparent, evidence-based review of available data, the Advisory Committee on Immunization Practices…
-
FDA issued Emergency Use Authorization for second COVID-19 vaccine
On Dec. 18, 2020, the FDA issued an emergency use authorization (EUA) for the second vaccine for the…
-
EC exercised option for additional 80 million doses of Moderna’s COVID-19 vaccine candidate
On Dec. 18, 2020, Moderna announced that the European Commission (EC) had exercised its option to purchase an…
-
Moderna announced FDA authorization of Moderna COVID-19 vaccine in U.S.
On Dec. 18, 2020, Moderna announced that the U.S. Food and Drug Administration (FDA) had authorized the emergency…
